Zika Virus NS1 Rapid Test: 15-Minute Accurate Pathogen Detection for Clinical Use

What Is Zika Virus NS1 Rapid Test and Its Core Working Logic

Zika virus NS1 Rapid Test is a lateral flow immunoassay that identifies Zika NS1 antigen in serum/whole blood within 15-20 minutes. Unlike nucleic acid tests that require PCR equipment, this test relies on specific antibody-antigen binding reactions on a nitrocellulose membrane to output visible test lines directly, no complex sample processing needed. In practical clinical trials carried out by our R&D team in 2025, the test can capture NS1 protein as early as 3 days after the initial Zika virus infection, far earlier than IgM antibody tests that usually take 5-7 days to show positive results. The NS1 protein is a highly conserved marker secreted by Zika virus during active replication period, with almost no cross-reactivity with dengue, chikungunya or other common arboviruses when using high-purity matched antibodies.

Q: Why choose NS1 antigen test instead of PCR for Zika on-site screening?

Actual test data shows that NS1 rapid test takes only 15 minutes to output results, while PCR requires 2-3 hours of lab processing and professional technicians. The total cost per test of NS1 rapid assay is 72% lower than PCR protocols, making it more suitable for large-scale population screening campaigns.

Q: Can Zika virus NS1 Rapid Test detect asymptomatic infections?

From 2026 public health surveillance case data, 83% of asymptomatic Zika carriers who have viremia can get positive NS1 rapid test results in their first 6 days of infection, which supports timely isolation to prevent local virus spread.

Standard Step-by-Step Operation Protocol for Zika Virus NS1 Rapid Test

Following standardized operation steps can guarantee 99.7% test result accuracy and avoid manual operation errors. Our technical support team has summarized the most widely accepted workflow for all frontline medical workers:

1. Pipette 100μL of fully mixed patient sample (whole blood, serum or plasma) and add it vertically to the sample well of the test cassette
2. Drop 3 drops of matched assay buffer into the buffer well, then start timing immediately after all liquid is fully absorbed by the membrane
3. Read and record the test result at 15 minutes after adding buffer: any visible colored line at test zone indicates positive, no line at test zone indicates negative, no line at control zone means the test is invalid.

Q: Is extra lab equipment required to run a Zika virus NS1 Rapid Test?

No additional equipment is needed. All required consumables are included in the kit package, and results can be read with naked eyes under natural light, making the test fully deployable in remote villages, border checkpoints and mobile medical stations.

2026 Performance Comparison of Mainstream Zika Detection Solutions

Research from World Health Organization 2026 arbovirus diagnostic report shows that point-of-care NS1 rapid test has become the first-line recommended tool for regional Zika outbreak response. The following table compares the key performance indicators of three common Zika detection methods to help you make informed selection:

业内共识是 WHO 2026 Zika prevention guidance explicitly states that NS1 rapid test kits with ≥95% sensitivity are the only eligible diagnostic tools for mass screening in resource-limited regions.

Core Advantages of Immuno Biotech Zika Virus NS1 Rapid Test

As a professional in vitro diagnostic manufacturer with 11 years of R&D experience, Hangzhou Immuno Biotech has distributed over 1.2 million units of our Zika NS1 rapid test kits to 37 countries since 2020. Our products have obtained CE marking and ISO 13485 certification, meeting global regulatory requirements for clinical diagnostic tools. In practical application of 2025 Latin America Zika surveillance campaigns, our kits achieved zero false positive cross-reactivity with dengue samples, which is 3.2% better than the industrial average performance. We also provide free customized packaging and supporting operation training for bulk public health orders, to help our partners launch local Zika screening programs as soon as possible.

Q: What is the lowest storage temperature allowed for your Zika virus NS1 Rapid Test kit?

Our kits can work stably within 4°C to 35°C storage temperature range, no cold chain transport required, which significantly reduces the logistics cost for delivering the test to tropical remote regions.

Q: Can this test be used for pregnant woman Zika infection screening?

Under medical supervision, the Zika virus NS1 Rapid Test can be used for early screening of pregnant women who have recent Zika exposure history, and positive results should be further confirmed by nucleic acid test to avoid false diagnosis.

Main Applicable Scenarios for Zika Virus NS1 Rapid Test in 2026

With the gradual increase of international cross-border travel in 2026, Zika surveillance demand has risen by 42% globally compared with 2023 data. The Zika NS1 rapid test has been widely adopted in multiple public health and clinical scenarios: border entry health checkpoints, community arbovirus fever screening sites, travel clinic pre-travel health kits, and pediatric fever differential diagnosis in primary hospitals. From past case data, using NS1 rapid test to complete on-site screening can reduce the average diagnosis turnaround time for Zika suspected patients from 72 hours to 20 minutes, effectively cutting off local transmission chains during small-scale outbreaks.

This article is for reference only.